Biology of Blood and Marrow Transplantation
Volume 15, Issue 6 , Pages 656-661 , June 2009

Current Status of Allogeneic Hematopoietic Stem Cell Transplantation for Paroxysmal Nocturnal Hemoglobinuria

  • Nelson A. Matos-Fernandez

      Affiliations

    • Department of Blood and Marrow Transplantation, Moffitt Cancer Center and Research Institute, Tampa, Florida
    • Department of Hematology and Medical Oncology, Veteran Affairs Caribbean Healthcare System, San Juan, Puerto Rico
    • The first 2 authors contributed equally to the manuscript.
    • ,
  • Yasser R. Abou Mourad

      Affiliations

    • Leukemia and Bone Marrow Transplantation Program of British Columbia, University of British Columbia, British Columbia Cancer Agency, Vancouver General Hospital, Vancouver, BC, Canada
    • The first 2 authors contributed equally to the manuscript.
    • ,
  • William Caceres

      Affiliations

    • Department of Hematology and Medical Oncology, Veteran Affairs Caribbean Healthcare System, San Juan, Puerto Rico
    • ,
  • Mohamed A. Kharfan-Dabaja

      Affiliations

    • Department of Blood and Marrow Transplantation, Moffitt Cancer Center and Research Institute, Tampa, Florida
    • Department of Oncological Sciences, Moffitt Cancer Center at the University of South Florida, Tampa, Florida
    • Corresponding Author InformationCorrespondence and reprint requests: Mohamed A. Kharfan-Dabaja, MD, FACP, Department of Blood and Marrow Transplantation, Moffitt Cancer Center, 12902 Magnolia Drive, BMT-WCB, Tampa, FL 33612.

Received 17 November 2008 ,Accepted 22 December 2008.

References 

  1. Crosby WH. Paroxysmal nocturnal hemoglobinuria: a classic description by Paul Strubing in 1882, and bibliography of the disease. Blood. 1951;6:270–284
  2. Socie G, Mary JY, De Gramont A, et al. Paroxysmal nocturnal hemoglobinuria: long-term follow-up and prognostic factors. Lancet. 1996;348:573–577
  3. Hillmen P, Lewis SM, Bessler M, Luzzatto L. Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med. 1995;333:1253–1258
  4. Nara K, Blessler M, Deeg HJ, Luzzatto L. New somatic mutation in the PIG-A gene emerges at relapse of paroxysmal nocturnal hemoglobinuria. Blood. 1998;92:3422–3427
  5. de Latour RP, Mary JY, Salanoubat C, et al. Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories. Blood. 2008;112:3099–3106
  6. Brodsky RA. Advances in the diagnosis and therapy of paroxysmal nocturnal hemoglobinuria. Blood Rev. 2008;22:65–74
  7. Hall SE, Rosse WF. The use of monoclonal antibodies and flow cytometry in the diagnosis of paroxysmal nocturnal hemoglobinuria. Blood. 1996;87:5332–5340
  8. Thomas TC, Rollins SA, Rother RP, et al. Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv. Mol Immunol. 1996;33:1389–1401
  9. Hillmen P, Young NS, Schubert J, et al. The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med. 2006;355:1233–1243
  10. Brodsky RA, Young NS, Antonioli E, et al. Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria. Blood. 2008;111:1840–1847
  11. Rosse WF, Nishimura J. Clinical manifestations of paroxysmal nocturnal hemoglobinuria: present state and future problems. Int J Hematol. 2003;77:113–120
  12. Hill A, Richards SJ, Hillmen P. Recent developments in the understanding and management of paroxysmal nocturnal haemoglobinuria. Br J Haematol. 2007;137:181–192
  13. Gluckman E, Devergie A, Dutreix A, et al. Bone marrow grafting in aplasic anemia after conditioning with cyclophosphamide and total body irradiation with lung shielding. Haematol Blood Transfus. 1980;25:339–347
  14. Ham TH. Studies on destruction of red blood cells: I. chronic hemolyitic anemia with paroxysmal nocturnal hemoglobinuria: an investigation of the mechanism of hemolysis, with observation on five cases. Arch Intern Med. 1939;64:1271
  15. Hartmann RC, Jenkins DE. The “sugar-water” test for paroxysmal nocturnal hemoglobinuria. N Engl J Med. 1966;275:155–157
  16. Richards SJ, Rawstron AC, Hillmen P. Application of flow cytometry to the diagnosis of paroxysmal nocturnal hemoglobinuria. Cytometry. 2000;42:223–233
  17. Rosse WF. Transfusion in paroxysmal nocturnal hemoglobinuria. To wash or not to wash?. Transfusion. 1989;29:663–634
  18. Harrington WJ, Kolodny L, Horstman LL, Ahn YS. Danazol for paroxysomal nocturnal hemoglobinuria. Am J Hematol. 1997;54:149–154
  19. Katayama Y, Hiramatsu Y, Kohriyama K. Monitoring of CD59 expression in paroxysmal nocturnal hemoglobinuria treated with danazol. Am J Hematol. 2001;68:280–283
  20. Hall C, Richards S, Hillmen P. Primary prophylaxis with warfarin prevents thrombosis in paroxysmal nocturnal hemoglobinuria (PNH). Blood. 2003;102:3587–3591
  21. Szer J, Deeg J, Witherspoon R, et al. Long-term survival after marrow transplantation for paroxysmal nocturnal hemoglobinuria with aplastic anemia. Ann Intern Med. 1984;101:193–195
  22. Antin JH, Ginsburg D, Smith BR, Nathan DG, Orkin SH, Rappeport JM. Bone marrow transplantation for paroxysmal nocturnal hemoglobinuria: eradication of the PNH clone and documentation of complete lymphohematopoietic engraftment. Blood. 1985;66:1247–1250
  23. Takahashi Y, McCoy JP, Carvallo C, et al. In vitro and in vivo evidence of PNH cell sensitivity to immune attack after nonmyeloablative allogeneic hematopoietic cell transplantation. Blood. 2004;103:1383–1390
  24. Bemba M, Guardiola P, Garderet L, et al. Bone marrow transplantation for paroxysmal nocturnal haemoglobinuria. Br J Haematol. 1999;105:366–368
  25. Saso R, Marsh J, Cevreska L, et al. Bone marrow transplants for paroxysmal nocturnal haemoglobinuria. Br J Haematol. 1999;104:392–396
  26. Raiola AM, Lint Van, Lamparelli T, et al. Bone marrow transplantation for paroxysmal nocturnal hemoglobinuria. Haematologica. 2000;85:59–62
  27. Kawahara K, Witherspoon RP, Storb R. Marrow transplantation for paroxysmal nocturnal hemoglobinuria. Am J Hematol. 1992;39:283–288
  28. Lee JL, Lee JH, Lee JH, et al. Allogeneic hematopoietic cell transplantation for paroxysmal nocturnal hemoglobinuria. Eur J Haematol. 2003;71:114–118
  29. Woodward P, Wang W, Pitts N, et al. Succesful unrelated donor bone marrow transplantation for paroxysmal nocturnal hemoglobinuria. Bone Marrow Transplant. 2001;27:589–592
  30. Flotho C, Strahm B, Kontny U, et al. Stem cell transplantation for paroxysmal nocturnal haemoglobinuria in childhood. Br J Haematol. 2002;118:124–127
  31. Hegenbart U, Niederwieser D, Forman S, et al. Hematopoietic cell transplantation from related and unrelated donors after minimal conditioning as a curative treatment modality for severe paroxysmal nocturnal hemoglobinuria. Biol Blood Marrow Transplant. 2003;9:689–697
  32. Brodsky RA, Luznik L, Bolanos-Meade J, et al. Reduced intensity HLA-haploidentical BMT with post transplantation cyclophosphamide in nonmalignant hematologic diseases. Bone Marrow Transplant. 2008;42:523–527
  33. Kharfan-Dabaja MA, Anasetti C, Santos ES. Hematopoietic cell transplantation for chronic lymphocytic leukemia: an evolving concept. Biol Blood Marrow Transplant. 2007;13:373–385
  34. de Lima M, Anagnostopoulos A, Munsell M, et al. Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation. Blood. 2004;104:865–872

 Financial disclosure: See Acknowledgments on page 660.

PII: S1083-8791(08)01231-7

doi: 10.1016/j.bbmt.2008.12.507

Biology of Blood and Marrow Transplantation
Volume 15, Issue 6 , Pages 656-661 , June 2009

Article Tools